Protein Phosphatase 2A as a Therapeutic Target in Acute Myeloid Leukemia
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Protein Phosphatase 2A as a Therapeutic Target in Acute Myeloid Leukemia
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 6, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2016-04-06
DOI
10.3389/fonc.2016.00078
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- PKR inhibits the DNA damage response, and is associated with poor survival in AML and accelerated leukemia in NHD13 mice
- (2015) X. Cheng et al. BLOOD
- Management of Relapsed/Refractory Acute Myeloid Leukemia in the Elderly: Current Strategies and Developments
- (2015) Jeffrey C. Bryan et al. DRUGS & AGING
- CIP2A high expression is a poor prognostic factor in normal karyotype acute myeloid leukemia
- (2015) E. Barragan et al. HAEMATOLOGICA
- Lipid Nanosystems Enhance the Bioavailability and the Therapeutic Efficacy of FTY720 in Acute Myeloid Leukemia
- (2015) A. Estella-Hermoso de Mendoza et al. Journal of Biomedical Nanotechnology
- Second generation tyrosine kinase inhibitors prevent disease progression in high-risk (high CIP2A) chronic myeloid leukaemia patients
- (2015) C M Lucas et al. LEUKEMIA
- Acute Myeloid Leukemia
- (2015) Hartmut Döhner et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Nuclear Oncogene SET Controls DNA Repair by KAP1 and HP1 Retention to Chromatin
- (2015) Alkmini Kalousi et al. Cell Reports
- CIP2A high expression is a poor prognostic factor in normal karyotype acute myeloid leukemia
- (2015) E. Barragan et al. HAEMATOLOGICA
- Treatment of Acute Myeloid Leukemia in Adolescent and Young Adult Patients
- (2015) Guldane Seval et al. Journal of Clinical Medicine
- Molecular Genetic Markers in Acute Myeloid Leukemia
- (2015) Sophia Yohe Journal of Clinical Medicine
- Therapeutic Re-Activation of Protein Phosphatase 2A in Acute Myeloid Leukemia
- (2015) Kavitha Ramaswamy et al. Frontiers in Oncology
- The Interplay between PP2A and microRNAs in Leukemia
- (2015) Peter P. Ruvolo Frontiers in Oncology
- From the Biology of PP2A to the PADs for Therapy of Hematologic Malignancies
- (2015) Maria Ciccone et al. Frontiers in Oncology
- High Expression of c-kit mRNA Predicts Unfavorable Outcome in Adult Patients with t(8;21) Acute Myeloid Leukemia
- (2015) Xiaoning Gao et al. PLoS One
- The protein phosphatase 2A regulatory subunit B55α is a modulator of signaling and microRNA expression in acute myeloid leukemia cells
- (2014) Peter P. Ruvolo et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Ser70 phosphorylation of Bcl-2 by selective tyrosine nitration of PP2A-B56 stabilizes its antiapoptotic activity
- (2014) I. C. C. Low et al. BLOOD
- Silencing of STRN4 suppresses the malignant characteristics of cancer cells
- (2014) Meihong Wong et al. CANCER SCIENCE
- Deregulation of the PP2A Inhibitor SET Shows Promising Therapeutic Implications and Determines Poor Clinical Outcome in Patients with Metastatic Colorectal Cancer
- (2014) I. Cristobal et al. CLINICAL CANCER RESEARCH
- Antagonism of SET Using OP449 Enhances the Efficacy of Tyrosine Kinase Inhibitors and Overcomes Drug Resistance in Myeloid Leukemia
- (2014) A. Agarwal et al. CLINICAL CANCER RESEARCH
- Effect of FTY720 on the SET–PP2A complex in acute myeloid leukemia; SET binding drugs have antagonistic activity
- (2014) R Pippa et al. LEUKEMIA
- PP2A-Mediated Regulation of Ras Signaling in G2 Is Essential for Stable Quiescence and Normal G1 Length
- (2014) Nana Naetar et al. MOLECULAR CELL
- A PP1–PP2A phosphatase relay controls mitotic progression
- (2014) Agnes Grallert et al. NATURE
- Identification of a Recurrent STRN/ALK Fusion in Thyroid Carcinomas
- (2014) Gaëlle Pérot et al. PLoS One
- FTY720 Induces Apoptosis of M2 Subtype Acute Myeloid Leukemia Cells by Targeting Sphingolipid Metabolism and Increasing Endogenous Ceramide Levels
- (2014) Limin Chen et al. PLoS One
- Targeting c-MYC by antagonizing PP2A inhibitors in breast cancer
- (2014) M. Janghorban et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Identification of the transforming STRN-ALK fusion as a potential therapeutic target in the aggressive forms of thyroid cancer
- (2014) L. M. Kelly et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Basic Biology of PP2A in Hematologic Cells and Malignancies
- (2014) Dorien Haesen et al. Frontiers in Oncology
- Antagonistic activities of the immunomodulator and PP2A-activating drug FTY720 (Fingolimod, Gilenya) in Jak2-driven hematologic malignancies
- (2013) J. J. Oaks et al. BLOOD
- Phosphatase: PP2A structural importance, regulation and its aberrant expression in cancer
- (2013) Parthasarathy Seshacharyulu et al. CANCER LETTERS
- Cancerous Inhibitor of Protein Phosphatase 2A, an Emerging Human Oncoprotein and a Potential Cancer Therapy Target
- (2013) A. Khanna et al. CANCER RESEARCH
- Downregulation of PPP2R5E is a common event in acute myeloid leukemia that affects the oncogenic potential of leukemic cells
- (2013) I. Cristobal et al. HAEMATOLOGICA
- PP2A-activating drugs selectively eradicate TKI-resistant chronic myeloid leukemic stem cells
- (2013) Paolo Neviani et al. JOURNAL OF CLINICAL INVESTIGATION
- Protein phosphatase 2A: a target for anticancer therapy
- (2013) Danilo Perrotti et al. LANCET ONCOLOGY
- Ser9 phosphorylation causes cytoplasmic detention of I2PP2A/SET in Alzheimer disease
- (2013) Guang Yu et al. NEUROBIOLOGY OF AGING
- Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
- (2013) NEW ENGLAND JOURNAL OF MEDICINE
- Treatment for relapsed acute myeloid leukemia
- (2012) Yishai Ofran et al. CURRENT OPINION IN HEMATOLOGY
- Sphingosine analogue drug FTY720 targets I2PP2A/SET and mediates lung tumour suppression via activation of PP2A-RIPK1-dependent necroptosis
- (2012) Sahar A. Saddoughi et al. EMBO Molecular Medicine
- CIP2A is a predictor of survival and a novel therapeutic target in bladder urothelial cell carcinoma
- (2012) Yijun Xue et al. MEDICAL ONCOLOGY
- CIP2A signature reveals the MYC dependency of CIP2A-regulated phenotypes and its clinical association with breast cancer subtypes
- (2012) M Niemelä et al. ONCOGENE
- Phosphorylation of SET Protein at Ser171 by Protein Kinase D2 Diminishes Its Inhibitory Effect on Protein Phosphatase 2A
- (2012) Atsushi Irie et al. PLoS One
- SET oncoprotein overexpression in B-cell chronic lymphocytic leukemia and non-Hodgkin lymphoma: a predictor of aggressive disease and a new treatment target
- (2011) D. J. Christensen et al. BLOOD
- Cancerous inhibitor of PP2A (CIP2A) at diagnosis of chronic myeloid leukemia is a critical determinant of disease progression
- (2011) C. M. Lucas et al. BLOOD
- Anti-CD25 (daclizumab) monoclonal antibody therapy in relapsing–remitting multiple sclerosis
- (2011) Roland Martin CLINICAL IMMUNOLOGY
- Mechanism of inhibition of PP2A activity and abnormal hyperphosphorylation of tau by I2PP2A/SET
- (2011) Lisette Arnaud et al. FEBS LETTERS
- Overexpression of SET is a recurrent event associated with poor outcome and contributes to protein phosphatase 2A inhibition in acute myeloid leukemia
- (2011) I. Cristobal et al. HAEMATOLOGICA
- CIP2A is over-expressed in acute myeloid leukaemia and associated with HL60 cells proliferation and differentiation
- (2011) J. WANG et al. International Journal of Laboratory Hematology
- Reactivating PP2A by FTY720 as a Novel therapy for AML with C-KIT tyrosine kinase domain mutation
- (2011) Yan Yang et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Molecular Genetics of Adult Acute Myeloid Leukemia: Prognostic and Therapeutic Implications
- (2011) Guido Marcucci et al. JOURNAL OF CLINICAL ONCOLOGY
- Low expression of PP2A regulatory subunit B55α is associated with T308 phosphorylation of AKT and shorter complete remission duration in acute myeloid leukemia patients
- (2011) P P Ruvolo et al. LEUKEMIA
- PP2A impaired activity is a common event in acute myeloid leukemia and its activation by forskolin has a potent anti-leukemic effect
- (2011) I Cristóbal et al. LEUKEMIA
- Inhibition of Protein Phosphatase 2A Activity by PI3Kγ Regulates β-Adrenergic Receptor Function
- (2011) Neelakantan T. Vasudevan et al. MOLECULAR CELL
- Targeting SET/I2PP2A oncoprotein functions as a multi-pathway strategy for cancer therapy
- (2011) C H Switzer et al. ONCOGENE
- ATM-mediated phosphorylation activates the tumor-suppressive function of B56γ–PP2A
- (2011) G P Shouse et al. ONCOGENE
- CIP2A is Overexpressed in Non-Small Cell Lung Cancer and Correlates with Poor Prognosis
- (2010) Qian-Ze Dong et al. ANNALS OF SURGICAL ONCOLOGY
- The PP2A inhibitor SET regulates granzyme B expression in human natural killer cells
- (2010) R. Trotta et al. BLOOD
- Essential Requirement for PP2A Inhibition by the Oncogenic Receptor c-KIT Suggests PP2A Reactivation as a Strategy to Treat c-KIT+ Cancers
- (2010) K. G. Roberts et al. CANCER RESEARCH
- Identification of PP2A Complexes and Pathways Involved in Cell Transformation
- (2010) A. A. Sablina et al. CANCER RESEARCH
- PP2A:B56ϵ, a Substrate ofCaspase-3, Regulatesp53-dependent andp53-independent Apoptosis during Development
- (2010) Zhigang Jin et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Chronic myeloid leukemia: mechanisms of blastic transformation
- (2010) Danilo Perrotti et al. JOURNAL OF CLINICAL INVESTIGATION
- Multiple forms of PKR present in the nuclei of acute leukemia cells represent an active kinase that is responsive to stress
- (2010) W L Blalock et al. LEUKEMIA
- PP2AT61ɛ Is an Inhibitor of MAP4K3 in Nutrient Signaling to mTOR
- (2010) Lijun Yan et al. MOLECULAR CELL
- Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
- (2010) Jeffrey A. Cohen et al. NEW ENGLAND JOURNAL OF MEDICINE
- SETBP1 overexpression is a novel leukemogenic mechanism that predicts adverse outcome in elderly patients with acute myeloid leukemia
- (2009) I. Cristobal et al. BLOOD
- CIP2A Is Associated with Human Breast Cancer Aggressivity
- (2009) C. Come et al. CLINICAL CANCER RESEARCH
- Protein phosphatase 2A PR130/B″α1 subunit binds to the SH2 domain-containing inositol polyphosphate 5-phosphatase 2 and prevents epidermal growth factor (EGF)-induced EGF receptor degradation sustaining EGF-mediated signaling
- (2009) Karen Zwaenepoel et al. FASEB JOURNAL
- PKR activity is required for acute leukemic cell maintenance and growth: A role for PKR-mediated phosphatase activity to regulate GSK-3 phosphorylation
- (2009) William L. Blalock et al. JOURNAL OF CELLULAR PHYSIOLOGY
- MYC-Dependent Regulation and Prognostic Role of CIP2A in Gastric Cancer
- (2009) Anchit Khanna et al. JNCI-Journal of the National Cancer Institute
- The level of AKT phosphorylation on threonine 308 but not on serine 473 is associated with high-risk cytogenetics and predicts poor overall survival in acute myeloid leukaemia
- (2009) N Gallay et al. LEUKEMIA
- Optimal induction and post-remission therapy for AML in first remission
- (2009) J. M. Rowe Hematology-American Society of Hematology Education Program
- Protein phosphatase 2A regulatory subunits and cancer
- (2008) Pieter J.A. Eichhorn et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Molecular profiling of LGL leukemia reveals role of sphingolipid signaling in survival of cytotoxic lymphocytes
- (2008) M. V. Shah et al. BLOOD
- PKR Regulates B56α-mediated BCL2 Phosphatase Activity in Acute Lymphoblastic Leukemia-derived REH Cells
- (2008) Vivian R. Ruvolo et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- PP2A holoenzyme assembly: in cauda venenum (the sting is in the tail)
- (2008) Veerle Janssens et al. TRENDS IN BIOCHEMICAL SCIENCES
- Multiple pathways regulated by the tumor suppressor PP2A in transformation
- (2008) Jukka Westermarck et al. TRENDS IN MOLECULAR MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search